본문 바로가기
KERD
논문KCI 등재

Recent Advance in Very Early Onset Inflammatory Bowel Disease

Jung Ok Shim
대한소아소화기영양학회 (The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition)|2019.01|Pediatric Gastroenterology, Hepatology & Nutrition|제22권 제1호|pp. 41-49|DOI 10.5223/pghn.2019.22.1.41

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

.ChildInfantMutationVery early-onset inflammatory bowel disease
주제분류소아과학

초록

Recent studies on pediatric inflammatory bowel disease (IBD) have revealed that early-onset IBD has distinct phenotypic differences compared with adult-onset IBD. In particular, very early-onset IBD (VEO-IBD) differs in many aspects, including the disease type, location of the lesions, disease behavior, and genetically attributable risks. Several genetic defects that disturb intestinal epithelial barrier function or affect immune function have been noted in these patients from the young age groups. In incidence of pediatric IBD in Korea has been increasing since the early 2000s. Neonatal or infantile-onset IBD develops in less than 1% of pediatric patients. Children with “neonatal IBD” or “infantile-onset IBD” have higher rates of affected first-degree relatives, severe disease course, and a high rate of resistance to immunosuppressive treatment. The suspicion of a monogenic cause of VEO-IBD was first confirmed by the discovery of mutations in the genes encoding the interleukin 10 (IL-10) receptors that cause impaired IL-10 signaling. Patients with such mutations typically presented with perianal fistulae, shows a poor response to medical management, and require early surgical interventions in the first year of life. To date, 60 monogenic defects have been identified in children with IBD-like phenotypes. The majority of monogenic defects presents before 6 years of age, and many present before 1 year of age. Next generation sequencing could become an important diagnostic tool in children with suspected genetic defects especially in children with VEO-IBD with severe disease phenotypes. VEO-IBD is a phenotypically and genetically distinct disease entity from adult-onset or older pediatric IBD.

Abstract

Recent studies on pediatric inflammatory bowel disease (IBD) have revealed that early-onset IBD has distinct phenotypic differences compared with adult-onset IBD. In particular, very early-onset IBD (VEO-IBD) differs in many aspects, including the disease type, location of the lesions, disease behavior, and genetically attributable risks. Several genetic defects that disturb intestinal epithelial barrier function or affect immune function have been noted in these patients from the young age groups. In incidence of pediatric IBD in Korea has been increasing since the early 2000s. Neonatal or infantile-onset IBD develops in less than 1% of pediatric patients. Children with “neonatal IBD” or “infantile-onset IBD” have higher rates of affected first-degree relatives, severe disease course, and a high rate of resistance to immunosuppressive treatment. The suspicion of a monogenic cause of VEO-IBD was first confirmed by the discovery of mutations in the genes encoding the interleukin 10 (IL-10) receptors that cause impaired IL-10 signaling. Patients with such mutations typically presented with perianal fistulae, shows a poor response to medical management, and require early surgical interventions in the first year of life. To date, 60 monogenic defects have been identified in children with IBD-like phenotypes. The majority of monogenic defects presents before 6 years of age, and many present before 1 year of age. Next generation sequencing could become an important diagnostic tool in children with suspected genetic defects especially in children with VEO-IBD with severe disease phenotypes. VEO-IBD is a phenotypically and genetically distinct disease entity from adult-onset or older pediatric IBD.

참고문헌 (79)

  1. Moran CJ, "Very early onset inflammatory bowel disease", Semin Pediatr Surg, 26, pp.356~359 (2017)
  2. 서정기, "소아기에 발병하는 염증성장질환(IBD)은 성인 IBD와 다른 질환인가? - 조기발병 소아 IBD의 역학적, 임상적, 유전학적 특성 및 치료 시 고려 사항-", Pediatric Gastroenterology, Hepatology & Nutrition, 14(1), pp.1~25 (2011), 대한소아소화기영양학회
  3. Uhlig HH, "The diagnostic approach to monogenic very early onset inflammatory bowel disease", Gastroenterology, 147, pp.990~1007.e3 (2014)
  4. Ekbom A, "The epidemiology of inflammatory bowel disease : a large, population-based study in Sweden", Gastroenterology, 100, pp.350~358 (1991)
  5. Loftus EV Jr, "Clinical epidemiology of inflammatory bowel disease : incidence, prevalence, and environmental influences", Gastroenterology, 126, pp.1504~1517 (2004)
  6. Benchimol EI, "Epidemiology of pediatric inflammatory bowel disease : a systematic review of international trends", Inflamm Bowel Dis, 17, pp.423~439 (2011)
  7. Benchimol EI, "Changing age demographics of inflammatory bowel disease in Ontario, Canada : a population-based cohort study of epidemiology trends", Inflamm Bowel Dis, 20, pp.1761~1769 (2014)
  8. Grieci T, "The incidence of inflammatory bowel disease in the pediatric population of Southwestern Ontario", J Pediatr Surg, 44, pp.977~980 (2009)
  9. Shim JO, "Treatment patterns and prognosis of inflammatory bowel disease: a nationwide epidemiologic study", Paper presented at: Korean Digestive Disease Week (KDDW), 2017, pp.100~ (2017)
  10. "J Crohns Colitis", 2017, 519~526
  11. Levine A, "Pediatric modification of the Montreal classification for inflammatory bowel disease : the Paris classification", Inflamm Bowel Dis, 17, pp.1314~1321 (2011)
  12. Hyams JS, "Standardized recording of parameters related to the natural history of inflammatory bowel disease : from Montreal to Paris", Dig Dis, 32, pp.337~344 (2014)
  13. Doecke JD, "Genetic susceptibility in IBD : overlap between ulcerative colitis and Crohn's disease", Inflamm Bowel Dis, 19, pp.240~245 (2013)
  14. Liu JZ, "Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations", Nat Genet, 47, pp.979~986 (2015)
  15. Zhang Y, "Bayesian analysis of genome-wide inflammatory bowel disease data sets reveals new risk loci", Eur J Hum Genet, 26, pp.265~274 (2018)
  16. Yang SK, "Genome-wide association study of Crohn's disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations", Gut, 63, pp.80~87 (2014)
  17. Essers JB, "Established genetic risk factors do not distinguish early and later onset Crohn's disease", Inflamm Bowel Dis, 15, pp.1508~1514 (2009)
  18. Glocker EO, "Inflammatory bowel disease and mutations affecting the interleukin-10 receptor", N Engl J Med, 361, pp.2033~2045 (2009)
  19. Shim JO, "Very early-onset inflammatory bowel disease(IBD)in infancy is a different disease entity from adult-onset IBD; one form of interleukin-10 receptor mutations", J Hum Genet, 59, pp.337~341 (2014)
  20. Shim JO, "Interleukin-10 receptor mutations in children with neonatal-onset Crohn's disease and intractable ulcerating enterocolitis", Eur J Gastroenterol Hepatol, 25, pp.1235~1240 (2013)
  21. Worthey EA, "Making a definitive diagnosis : successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease", Genet Med, 13, pp.255~262 (2011)
  22. Kim SC, "Monozygotic twin cases of XIAP deficiency syndrome", J Pediatr Gastroenterol Nutr, 67, pp.e101~ (2018)
  23. Barzaghi F, "Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome : a paradigm of immunodeficiency with autoimmunity", Front Immunol, 3, pp.211~ (2012)
  24. Caudy AA, "CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4lymphocytes", J Allergy Clin Immunol, 119, pp.482~487 (2007)
  25. Uzel G, "Dominant gain-of-function STAT1mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome", J Allergy Clin Immunol, 131, pp.1611~1623 (2013)
  26. Kotlarz D, "Loss of interleukin-10 signaling and infantile inflammatory bowel disease : implications for diagnosis and therapy", Gastroenterology, 143, pp.347~355 (2012)
  27. Li Q, "Variants in TRIM22 that affect NOD2signaling are associated with very-early-onset inflammatory bowel disease", Gastroenterology, 150, pp.1196~1207 (2016)
  28. Blaydon DC, "Inflammatory skin and bowel disease linked to ADAM17 deletion", N Engl J Med, 365, pp.1502~1508 (2011)
  29. Freeman EB, "Gastrointestinal complications of epidermolysis bullosa in children", Br J Dermatol, 158, pp.1308~1314 (2008)
  30. Hayes P, "Defects in NADPH oxidase genes NOX1and DUOX2 in very early onset inflammatory bowel disease", Cell Mol Gastroenterol Hepatol, 1, pp.489~502 (2015)
  31. Fiskerstrand T, "Familial diarrhea syndrome caused by an activating GUCY2C mutation", N Engl J Med, 366, pp.1586~1595 (2012)
  32. Cheng LE, "Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome", Clin Immunol, 132, pp.124~131 (2009)
  33. Avitzur Y, "Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease", Gastroenterology, 146, pp.1028~1039 (2014)
  34. Schäppi MG, "Colitis in chronic granulomatous disease", Arch Dis Child, 84, pp.147~151 (2001)
  35. Matute JD, "A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity", Blood, 114, pp.3309~3315 (2009)
  36. Al-Bousafy A, "Libyan boy with autosomal recessive trait(P22-phox defect)of chronic granulomatous disease", Libyan J Med, 1, pp.162~171 (2006)
  37. Huang C, "Genetic risk for inflammatory bowel disease is a determinant of Crohn's disease development in chronic granulomatous disease", Inflamm Bowel Dis, 22, pp.2794~2801 (2016)
  38. Bégin P, "Inflammatory bowel disease and T cell lymphopenia in G6PC3 deficiency", J Clin Immunol, 33, pp.520~525 (2013)
  39. Visser G, "Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib : results of the European Study on Glycogen Storage Disease type I", J Pediatr, 137, pp.187~191 (2000)
  40. D'Agata ID, "Leucocyte adhesion deficiency presenting as a chronic ileocolitis", Gut, 39, pp.605~608 (1996)
  41. Kuehn HS, "Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4", Science, 345, pp.1623~1627 (2014)
  42. Meeths M, "Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2", Blood, 116, pp.2635~2643 (2010)
  43. Zeissig Y, "XIAP variants in male Crohn's disease", Gut, 64, pp.66~76 (2015)
  44. Booth C, "X-linked lymphoproliferative disease due to SAP", SH2D1A deficiency : a multicenter study on the manifestations, management and outcome of the disease, 2011, pp.117, 53~62
  45. Sari S, "The familial Mediterranean fever(MEFV)gene may be a modifier factor of inflammatory bowel disease in infancy", Eur J Pediatr, 167, pp.391~393 (2008)
  46. Villani AC, "Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis", PLoS One, 4, pp.e7154~ (2009)
  47. Hazzan D, "Crohn's-like colitis, enterocolitis and perianal disease in Hermansky-Pudlak syndrome", Colorectal Dis, 8, pp.539~543 (2006)
  48. Anderson PD, "Hermansky-Pudlak syndrome type 4(HPS-4) : clinical and molecular characteristics", Hum Genet, 113, pp.10~17 (2003)
  49. Mora AJ, "The management of gastrointestinal disease in Hermansky-Pudlak syndrome", J Clin Gastroenterol, 45, pp.700~702 (2011)
  50. Flanagan SE, "Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease", Nat Genet, 46, pp.812~814 (2014)
  51. Bader-Meunier B, "Mevalonate kinase deficiency : a survey of 50 patients", Pediatrics, 128, pp.e152~9 (2011)
  52. Zhou Q, "A hypermorphic missense mutation in PLCG2, encoding phospholipase C2, causes a dominantly inherited autoinflammatory disease with immunodeficiency", Am J Hum Genet, 91, pp.713~720 (2012)
  53. Agarwal S, "Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes", J Allergy Clin Immunol, 124, pp.658~664 (2009)
  54. Conley ME, "Agammaglobulinemia and absent B lineage cells in a patient lacking the p85 subunit of PI3K", J Exp Med, 209, pp.463~470 (2012)
  55. Takahashi N, "Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOSdeficient patients", J Immunol, 182, pp.5515~5527 (2009)
  56. Burns SO, "LRBA gene deletion in a patient presenting with autoimmunity without hypogammaglobulinemia", J Allergy Clin Immunol, 130, pp.1428~1432 (2012)
  57. Salzer E, "Early-onset inflammatory bowel disease and common variable immunodeficiency-like disease caused by IL-21 deficiency", J Allergy Clin Immunol, 133, pp.1651~1659 (2014)
  58. Knight SW, "Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia(Hoyeraal-Hreidarsson syndrome)due to mutations in the dyskeratosis congenita gene, DKC1", Br J Haematol, 107, pp.335~339 (1999)
  59. Ballew BJ, "A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndrome", PLoS Genet, 9, pp.e1003695~ (2013)
  60. Sanal O, "Additional diverse findings expand the clinical presentation of DOCK8 deficiency", J Clin Immunol, 32, pp.698~708 (2012)
  61. Levy J, "Clinical spectrum of X-linked hyper-IgM syndrome", J Pediatr, 131, pp.47~54 (1997)
  62. Quartier P, "Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency", Clin Immunol, 110, pp.22~29 (2004)
  63. Arnaiz-Villena A, "Brief report : primary immunodeficiency caused by mutations in the gene encoding the CD3-gamma subunit of the T-lymphocyte receptor", N Engl J Med, 327, pp.529~533 (1992)
  64. Chan AY, "A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70", J Exp Med, 213, pp.155~165 (2016)
  65. de Saint-Basile G, "Genetic study of a new X-linked recessive immunodeficiency syndrome", J Clin Invest, 89, pp.861~866 (1992)
  66. Felgentreff K, "Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency", Clin Immunol, 141, pp.73~82 (2011)
  67. Ozgür TT, "Hematopoietic stem cell transplantation in a CD3 gamma-deficient infant with inflammatory bowel disease", Pediatr Transplant, 12, pp.910~913 (2008)
  68. de Saint Basile G, "Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3", J Clin Invest, 114, pp.1512~1517 (2004)
  69. Rohr J, "Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency", J Clin Immunol, 30, pp.314~320 (2010)
  70. Moshous D, "Artemis, a novel DNA double-strand break repair", V(D)J recombination protein, is mutated in human severe combined immune deficiency, 2001, pp.105, 177~186
  71. Catucci M, "Autoimmunity in wiskott-Aldrich syndrome : an unsolved enigma", Front Immunol, 3, pp.209~ (2012)
  72. Stengaard-Pedersen K, "Inherited deficiency of mannan-binding lectin-associated serine protease 2", N Engl J Med, 349, pp.554~560 (2003)
  73. Fabre A, "SKIV2L mutations cause syndromic diarrhea, or trichohepatoenteric syndrome", Am J Hum Genet, 90, pp.689~692 (2012)
  74. Aiuti A, "Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome", Science, 341, pp.1233151~ (2013)
  75. Barzaghi F, "Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome", J Autoimmun, 38, pp.49~58 (2012)
  76. Rialon KL, "Long-term outcomes for children with very early-onset colitis : implications for surgical management", J Pediatr Surg, 53, pp.964~967 (2018)
  77. Samuels ME, "Exome sequencing identifies mutations in the gene TTC7A in French-Canadian cases with hereditary multiple intestinal atresia", J Med Genet, 50, pp.324~329 (2013)
  78. Benchimol EI, "Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease", Gastroenterology, 147, pp.803~813 (2014)
  79. Kwang Yeon Kim, "Higher Morbidity of Monogenic Inflammatory Bowel Disease Compared to the Adolescent Onset Inflammatory Bowel Disease", Pediatric Gastroenterology, Hepatology & Nutrition, 21(1), pp.34~42 (2018), 대한소아소화기영양학회

관련 논문AI추천

Very Early-Onset Inflammatory Bowel Disease: A Challenging Field for Pediatric GastroenterologistsKatsuhiro Arai대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2020 · 제23권 제5호Higher Morbidity of Monogenic Inflammatory Bowel Disease Compared to the Adolescent Onset Inflammatory Bowel Disease문진수, Eun Joo Lee, Hye Ran Yang, Jae Sung Ko, Ju Whi Kim, Ju Young Jang, Kwang Yeon Kim대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2018 · 제21권 제1호Clinical Aspects and Treatments for Pediatric Inflammatory Bowel DiseasesJin Soo Moon대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2019 · 제22권 제1호소아기에 발병하는 염증성장질환(IBD)은 성인 IBD와 다른 질환인가? - 조기발병 소아 IBD의 역학적, 임상적, 유전학적 특성 및 치료 시 고려 사항-서정기대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2011 · 제14권 제1호Characteristics of Pediatric Inflammatory Bowel Disease in Korea: Comparison with EUROKIDS Data김영호, 김은란, 박동일, 석정윤, 이강문, 이창균, 최성연, 허규찬, Hyeon Ah Lee거트앤리버 소화기연관학회협의회 · Gut and Liver2015 · 제9권 제6호Korean Children and Adolescents with Crohn's Disease Are More Likely to Present with Perianal Fistulizing Disease at Diagnosis Compared to Their European Counterparts이유민, 이지현, 최병호, 최연호, Ben Kang, Haejeong Lee, Hong Koh, Hyo-Jeong Jang, Jae Hun Jung, Jae Young Choe, Ji-Hyuk Lee, Jung-Eun Kim, Ju Young Kim, Mi Jin Kim, Seung Kim, So Yoon Choi, Yoon Lee, Youjin Choi대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2020 · 제23권 제1호

이 간행물의 다른 논문 (11건)

Clinical Practice Guideline for the Diagnosis and Treatment of Pediatric Obesity: Recommendations from the Committee on Pediatric Obesity of the Korean Society of Pediatric Gastroenterology Hepatology and NutritionYoon Lee, Eun Hye Lee, Yeoun Joo Lee, Jung Ok Shim, Ki Soo Kang, Dae Yong Yi, Ji Hyuk Lee, Jeana Hong, Hong Koh, JeongAe You, Young-Sook Kwak, Hyunjung Lim, Hye Ran Yang, Mi Jin Kim, Soon Chul Kim, Jin Soo Moon, 강빈, Jae Young Kim, Yong Joo Kimpp. 1-27Successful Transition from Pediatric to Adult Care in Inflammatory Bowel Disease: What is the Key?Jeongseok Kim, Byong Duk Yepp. 28-40Clinical Aspects and Treatments for Pediatric Inflammatory Bowel DiseasesJin Soo Moonpp. 50-56Usefulness of Ultrasonography in the Diagnosis of Peptic UlcerDisease in ChildrenEun Joo Lee, Jae Hong Park, Yeoun Joo Leepp. 57-62Dosage-Related Prebiotic Effects of Inulin in Formula-Fed InfantsMohammad Juffrie, Tonny Sundjaya, Jacques Bindels, Frieda Handayani, Hanifah Oswari, Ariani Dewi Widodo, Badriul Hegarpp. 63-71
원문 보기